H Lundbeck A/S (HLUN-A) - Total Assets

Latest as of December 2025: Dkr54.01 Billion DKK ≈ $8.45 Billion USD

Based on the latest financial reports, H Lundbeck A/S (HLUN-A) holds total assets worth Dkr54.01 Billion DKK (≈ $8.45 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See H Lundbeck A/S (HLUN-A) shareholders funds for net asset value and shareholders' equity analysis.

H Lundbeck A/S - Total Assets Trend (2004–2025)

This chart illustrates how H Lundbeck A/S's total assets have evolved over time, based on quarterly financial data.

H Lundbeck A/S - Asset Composition Analysis

Current Asset Composition (December 2025)

H Lundbeck A/S's total assets of Dkr54.01 Billion consist of 23.7% current assets and 76.3% non-current assets.

Asset Category	Amount (DKK)	% of Total Assets
Cash & Equivalents	Dkr0.00	6.4%
Accounts Receivable	Dkr4.55 Billion	8.4%
Inventory	Dkr4.47 Billion	8.3%
Property, Plant & Equipment	Dkr0.00	0.0%
Intangible Assets	Dkr28.77 Billion	53.3%
Goodwill	Dkr7.01 Billion	13.0%

Asset Composition Trend (2004–2025)

This chart illustrates how H Lundbeck A/S's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see H Lundbeck A/S (HLUN-A) market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: H Lundbeck A/S's current assets represent 23.7% of total assets in 2025, a decrease from 51.7% in 2004.
Cash Position: Cash and equivalents constituted 6.4% of total assets in 2025, down from 25.2% in 2004.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 65.0% of total assets, an increase from 14.0% in 2004.
Asset Diversification: The largest asset category is intangible assets at 53.3% of total assets.

H Lundbeck A/S Competitors by Total Assets

Key competitors of H Lundbeck A/S based on total assets are shown below.

Company	Country	Total Assets
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Regencell Bioscience Holdings Ltd NASDAQ:RGC	USA	$5.76 Million
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥31.46 Billion
Yuhan Corp. KO:000100	Korea	₩3.05 Trillion
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	China	CN¥8.15 Billion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	China	CN¥5.17 Billion
Guobang Pharma Ltd SHG:605507	China	CN¥10.58 Billion

H Lundbeck A/S - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.44	1.52	1.02
Quick Ratio	0.94	1.05	0.69
Cash Ratio	0.00	0.00	0.00
Working Capital	Dkr3.93 Billion	Dkr4.43 Billion	Dkr143.00 Million

H Lundbeck A/S - Advanced Valuation Insights

This section examines the relationship between H Lundbeck A/S's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.41
Latest Market Cap to Assets Ratio	0.02
Asset Growth Rate (YoY)	-5.2%
Total Assets	Dkr54.01 Billion
Market Capitalization	$1.09 Billion USD

Valuation Analysis

Below Book Valuation: The market values H Lundbeck A/S's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: H Lundbeck A/S's assets decreased by 5.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for H Lundbeck A/S (2004–2025)

The table below shows the annual total assets of H Lundbeck A/S from 2004 to 2025.

Year	Total Assets	Change
2025-12-31	Dkr54.01 Billion ≈ $8.45 Billion	-5.20%
2024-12-31	Dkr56.98 Billion ≈ $8.91 Billion	+52.31%
2023-12-31	Dkr37.41 Billion ≈ $5.85 Billion	-0.12%
2022-12-31	Dkr37.45 Billion ≈ $5.86 Billion	+8.08%
2021-12-31	Dkr34.65 Billion ≈ $5.42 Billion	-3.82%
2020-12-31	Dkr36.03 Billion ≈ $5.64 Billion	+0.76%
2019-12-31	Dkr35.76 Billion ≈ $5.59 Billion	+55.39%
2018-12-31	Dkr23.01 Billion ≈ $3.60 Billion	+16.48%
2017-12-31	Dkr19.76 Billion ≈ $3.09 Billion	-2.25%
2016-12-31	Dkr20.21 Billion ≈ $3.16 Billion	-5.23%
2015-12-31	Dkr21.32 Billion ≈ $3.34 Billion	-16.82%
2014-12-31	Dkr25.64 Billion ≈ $4.01 Billion	+8.41%
2013-12-31	Dkr23.65 Billion ≈ $3.70 Billion	+9.67%
2012-12-31	Dkr21.56 Billion ≈ $3.37 Billion	+5.01%
2011-12-31	Dkr20.53 Billion ≈ $3.21 Billion	+14.05%
2010-12-31	Dkr18.00 Billion ≈ $2.82 Billion	+5.13%
2009-12-31	Dkr17.13 Billion ≈ $2.68 Billion	+35.86%
2008-12-31	Dkr12.61 Billion ≈ $1.97 Billion	+2.28%
2007-12-31	Dkr12.33 Billion ≈ $1.93 Billion	+5.98%
2006-12-31	Dkr11.63 Billion ≈ $1.82 Billion	+0.02%
2005-12-31	Dkr11.63 Billion ≈ $1.82 Billion	+1.04%
2004-12-31	Dkr11.51 Billion ≈ $1.80 Billion	--

About H Lundbeck A/S

CO:HLUN-A Denmark Drug Manufacturers - Specialty & Generic

Market Cap

$1.09 Billion

Dkr6.97 Billion DKK

Market Cap Rank

#8736 Global

#44 in Denmark

Share Price

Dkr35.00

Change (1 day)

-1.13%

52-Week Range

Dkr26.10 - Dkr39.65

All Time High

Dkr41.55